In this study, we report that primary glioma stem-like cells are targeted in their ability to form neurospheres by PARP inhibitors; moreover, mutant PTEN GBM cells are also sensitive to PARP inhibitors by increasing genomic instability leading to impaired G2/M arrest and MC. The gene discussed is PARP1; the disease is glioblastoma.